Middle East & Africa Cancer Diagnostics Market Size & Outlook
The cancer diagnostics market in Middle East & Africa is expected to reach a projected revenue of US$ 1,409.7 million by 2033. A compound annual growth rate of 3.0% is expected of Middle East & Africa cancer diagnostics market from 2026 to 2033.
Middle East & Africa Cancer Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cancer Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.51% in 2025.
Horizon Databook has segmented the Middle East & Africa cancer diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2021 to 2033.
Middle East & Africa Cancer Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
Instruments
Consumables
Services
Middle East & Africa Cancer Diagnostics Market Type Outlook (Revenue, USD Million , 2021-2033)
IVD
LDT
Imaging
Middle East & Africa Cancer Diagnostics Market IVD By Technology Outlook (Revenue, USD Million , 2021-2033)
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Other IVD Testing Technologies
Middle East & Africa Cancer Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Kidney Cancer
Liver Cancer
Pancreatic Cancer
Ovarian Cancer
Others
Middle East & Africa Cancer Diagnostics Market End use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Laboratories
Others
Middle East & Africa Cancer Diagnostics Market Test Type Outlook (Revenue, USD Million , 2021-2033)
Biopsy
Others
Reasons to subscribe to Cancer Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cancer Diagnostics Market Outlook databook
Our clientele includes a mix of Cancer Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Cancer Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Cancer Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa Cancer Diagnostics Market, 2021-2033 (US$M)